Botulinum toxin ingestion leads to a clinical syndrome characterized by cranial nerve palsies, oculobulbar weakness, and descending, symmetrical flaccid paralysis in the absence of fever. Affected patients do not complain of sensory deficits.
The diagnosis of botulism is a clinical one, confirmed by the detection of toxin in clinical samples.
Treatment relies on a combination of aggressive supportive care and the swift administration of antitoxin in suspected cases.
Botulism is a paralytic illness caused by the neurotoxin produced by Clostridium botulinum. C botulinum is a large, gram-positive anaerobic bacillus that primarily exists in the form of a spore until environmental conditions suitable for germination arise.
Clinical symptoms result from the entry of botulinum toxin into the systemic circulation.
Professor of Pediatrics
West Virginia University School of Medicine
LSN is an author of a reference cited in this topic.
Dr Linda Nield would like to gratefully acknowledge Dr Thomas P. Bleck, Dr Aimee Hodowanec, Dr Pavani Reddy, and Dr Teresa Zembower, previous contributors to this topic. TPB, AH, PR, and TZ declare that they have no competing interests.
Research Fellow and Medical Microbiologist
Wellcome Trust Sanger Institute
Department of Microbiology
FC declares that she has no competing interests.
Assistant Professor of Medicine
Division of Infectious Diseases
University of Vermont College of Medicine
CDH declares that he has no competing interests.
Chief and Professor of Medicine
Division of Infectious Diseases and International Health
University of Virginia Health System
WAP declares that he has no competing interests.
Use of this content is subject to our disclaimer